{{Rsnum
|rsid=841853
|Gene=SLC2A1
|Chromosome=1
|position=42935767
|Orientation=minus
|GMAF=0.3398
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=SLC2A1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 52.2 | 39.8 | 8.0
| HCB | 52.6 | 40.9 | 6.6
| JPT | 61.1 | 37.2 | 1.8
| YRI | 28.6 | 49.0 | 22.4
| ASW | 35.1 | 43.9 | 21.1
| CHB | 52.6 | 40.9 | 6.6
| CHD | 56.0 | 37.6 | 6.4
| GIH | 53.5 | 37.6 | 8.9
| LWK | 21.8 | 50.9 | 27.3
| MEX | 41.4 | 48.3 | 10.3
| MKK | 27.6 | 51.9 | 20.5
| TSI | 35.3 | 54.9 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21247498
|Title=Genetic variation of Glucose Transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis Risk in Communities (ARIC) Study
|OA=1
}}

{{PMID Auto
|PMID=22707195
|Title=Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis
}}

{{PMID|19587357|OA=1
}} A systematic meta-analysis of genetic association studies for diabetic retinopathy.

{{PMID Auto
|PMID=23480298
|Title=Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific
}}

{{PMID Auto
|PMID=23631762
|Title=Genotyping analysis and 18FDG uptake in breast cancer patients: a preliminary research
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}